Does Active Surveillance Benefit Patients With Metastatic RCC?

Active surveillance prior to initiating targeted therapy might benefit patients with metastatic renal cell carcinoma, since it delays therapy and toxicities.

Source: CancerNetwork - February 22, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: ASCO Genitourinary Cancers Symposium News Renal Cell Carcinoma Source Type: news